Nanotechnology and cancer – 2
Narrator: This is NIH Health Matters. I’m Joe Balintfy. An estimated 1.5 million adults were diagnosed with cancer in 2009, with more than 562,000 dying from it in that one year alone. But these statistics are on the decline and researchers expect that trend to continue, thanks to new technology, specifically nanotechnology.
Barker: Nanotechnology is a fairly simple concept.
Narrator: Dr. Anna Barker is with the National Cancer Institute. She says an early application has been delivery of existing drugs.
Barker: Where some of those drugs are actually performing much better. Why is that? Because you're delivering the drug more directly to the cancer cell, you’re sparing the normal cells.
Narrator: Learn more about nanotechnology and cancer at the website nano.cancer.gov. Health Matters is produced by the National Institutes of Health, part of the U.S. Department of Health and Human Services.
About NIH Radio
NIH Radio offers free audio news programs from the National Institutes of Health, your reliable source for health information.
All NIH Radio content is in the public domain and can be used without charge or restriction provided that it is not used to misrepresent our agency nor used to suggest we endorse any private organization, product, or service.
NIH Radio is a service of the Office of Communications & Public Liaison.